SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Cash from Investing Activities (2021)

SeaStar Medical Holding's (ICU) quarterly Cash from Investing Activities came in at $8132.0 in Q4 2021, up 284.15% on a QoQ basis from -$4416.0 in Q3 2021.

SeaStar Medical Holding (ICU) Cash from Investing Activities (2021) Analysis & Trends

SeaStar Medical Holding (ICU) has 1 years of Cash from Investing Activities data on file, last reported at $8132.0 in Q4 2021.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to $8132.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$105.6 million (changed N/A YoY) and the FY2021 annual result came in at -$105.6 million, changed N/A from the prior year.
  • Cash from Investing Activities advanced to $8132.0 in Q4 2021, from -$4416.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $8132.0 in Q4 2021 to a low of -$105.6 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 8,132.00
Dec 31, 2021 8,132.00
Sep 30, 2021 -4,416.00
Sep 30, 2021 -4,416.00
Jun 30, 2021 -3,716.00
Jun 30, 2021 -3,716.00
Mar 31, 2021 -105.57 Mn
Mar 31, 2021 -105.57 Mn